A detailed history of Jmac Enterprises LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Jmac Enterprises LLC holds 3,700 shares of JAZZ stock, worth $454,989. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,700
Previous 3,700 -0.0%
Holding current value
$454,989
Previous $394,000 4.57%
% of portfolio
0.07%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$115.19 - $132.77 $57,595 - $66,385
-500 Reduced 11.9%
3,700 $445,000
Q3 2023

Oct 19, 2023

SELL
$122.0 - $145.31 $73,200 - $87,186
-600 Reduced 12.5%
4,200 $543,000
Q2 2022

Jul 25, 2022

SELL
$141.59 - $168.66 $84,954 - $101,196
-600 Reduced 11.11%
4,800 $749,000
Q4 2021

Feb 14, 2022

BUY
$119.87 - $145.67 $647,298 - $786,617
5,400 New
5,400 $758,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.71B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Jmac Enterprises LLC Portfolio

Follow Jmac Enterprises LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jmac Enterprises LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jmac Enterprises LLC with notifications on news.